Literature DB >> 33253433

T1-weighted and T2-weighted Subtraction MR Images for Glioma Visualization and Grading.

Mohammed Goryawala1, Bhaswati Roy2, Rakesh K Gupta2, Andrew A Maudsley1.   

Abstract

BACKGROUND AND
PURPOSE: To evaluate the performance of multiparametric MR images in differentiation of different regions of the gross tumor area and for assessment of glioma grade.
METHODS: Forty-six glioma subjects (18 grade II, 11 grade III, and 17 grade IV) underwent a comprehensive MR and spectroscopic imaging procedure. Maps were generated by subtraction of T1-weighted images from contrast-enhanced T1-weighted images (ΔT1 map) and T1-weighted images from T2-weighted images (ΔT2 map). Regions of interest (ROIs) were positioned in normal-appearing white matter (NAWM), enhancing tumor, hyperintense T2, necrotic region, and immediate and distal peritumoral regions (IPR and DPR). Relative signal contrast was estimated as difference between mean intensities in ROIs and NAWM. Classification using support vector machines was applied to all image series to determine the efficacy of regional contrast measures for differentiation of low- and high-grade lesions and grade III and IV lesions.
RESULTS: ΔT1 and ΔT2 maps offered higher contrast as compared to other parametric maps in differentiating enhancing tumor and edematous regions, respectively, and provided the highest classification accuracy for differentiating low- and high-grade tumors, of 91% and 90.4%. Choline/N-acetylaspartate maps provided significant contrast for delineating IPR and DPR. For differentiating high-grade gliomas, ΔT2 and ΔT1 maps provided a mean accuracy of 90.9% and 88.2%, which was lower than that obtained using cerebral blood volume (93.7%) and choline/creatine (93.3%) maps.
CONCLUSION: This study showed that subtraction maps provided significant contrast in differentiating several regions of the gross tumor area and are of benefit for accurate tumor grading.
© 2020 American Society of Neuroimaging.

Entities:  

Keywords:  Brain tumor; MRI; MRSI; contrast; glioma; subtraction

Mesh:

Year:  2020        PMID: 33253433      PMCID: PMC9364956          DOI: 10.1111/jon.12800

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.324


  24 in total

1.  High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  R Stupp; J-C Tonn; M Brada; G Pentheroudakis
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

2.  Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.

Authors:  Benjamin M Ellingson; Taryar Zaw; Timothy F Cloughesy; Kourosh M Naeini; Shadi Lalezari; Sandy Mong; Albert Lai; Phioanh L Nghiemphu; Whitney B Pope
Journal:  J Magn Reson Imaging       Date:  2012-01-26       Impact factor: 4.813

3.  Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.

Authors:  James R Fink; Robert B Carr; Eiji Matsusue; Ramesh S Iyer; Jason K Rockhill; David R Haynor; Kenneth R Maravilla
Journal:  J Magn Reson Imaging       Date:  2011-10-14       Impact factor: 4.813

4.  Quantification of physiological and hemodynamic indices using T(1) dynamic contrast-enhanced MRI in intracranial mass lesions.

Authors:  Anup Singh; Mohammad Haris; Divya Rathore; Ankur Purwar; Manoj Sarma; Getaneh Bayu; Nuzhat Husain; Ram K Singh Rathore; Rakesh K Gupta
Journal:  J Magn Reson Imaging       Date:  2007-10       Impact factor: 4.813

5.  Study on a method to improve T1 image contrast by the subtraction technique for 3.0 T brain examination.

Authors:  Ham-Gyum Kim; Yeong-Cheol Heo; Jae-Hwan Cho
Journal:  Clin Imaging       Date:  2013-11-07       Impact factor: 1.605

6.  Data-driven grading of brain gliomas: a multiparametric MR imaging study.

Authors:  Massimo Caulo; Valentina Panara; Domenico Tortora; Peter A Mattei; Chiara Briganti; Emanuele Pravatà; Simone Salice; Antonio R Cotroneo; Armando Tartaro
Journal:  Radiology       Date:  2014-03-22       Impact factor: 11.105

7.  Quantitative contrast ratio comparison between T1 (TSE at 1.5T, FLAIR at 3T), magnetization prepared rapid gradient echo and subtraction imaging at 1.5T and 3T.

Authors:  Richard Keith Downs; Mariah Haider Bashir; Chin Kau Ng; Jens Olaf Heidenreich
Journal:  Quant Imaging Med Surg       Date:  2013-06

8.  Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma.

Authors:  D Croteau; L Scarpace; D Hearshen; J Gutierrez; J L Fisher; J P Rock; T Mikkelsen
Journal:  Neurosurgery       Date:  2001-10       Impact factor: 4.654

9.  Magnetic resonance image registration and subtraction in the assessment of minor changes in low grade glioma volume.

Authors:  S E J Connor; R Gunny; T Hampton; R O'gorman
Journal:  Eur Radiol       Date:  2004-07-14       Impact factor: 5.315

10.  Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial.

Authors:  Benjamin M Ellingson; Hyun J Kim; Davis C Woodworth; Whitney B Pope; Jonathan N Cloughesy; Robert J Harris; Albert Lai; Phioanh L Nghiemphu; Timothy F Cloughesy
Journal:  Radiology       Date:  2013-11-27       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.